Side Effects of nirmatrelvir and ritonavir: A Synthesis of Findings from 17 Studies

  1. Home
  2. Side Effects of nirmatrelvir and ritonavir
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of nirmatrelvir and ritonavir: A Synthesis of Findings from 17 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of nirmatrelvir and ritonavir: A Synthesis of Findings from 17 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Nirmatrelvir-ritonavir is a promising treatment for COVID-19, particularly in high-risk individuals. Studies have shown its effectiveness in preventing severe disease progression and reducing hospitalization rates. 17 It has also been found to be well-tolerated in most patients, with a low rate of discontinuation due to side effects. 7 However, specific populations, such as pregnant women and organ transplant recipients, require further research to understand the drug’s safety and efficacy in these contexts. 1 Moreover, the potential for drug-drug interactions remains a crucial concern. 11

Reasons for Side Effects

Nirmatrelvir-ritonavir’s side effects can stem from the drug’s mechanism of action and individual patient factors. Ritonavir inhibits the CYP3A enzyme, which is crucial for metabolizing various medications. This inhibition can lead to increased blood concentrations of other drugs, potentially causing adverse effects. 11 Additionally, nirmatrelvir-ritonavir can cause side effects such as gastrointestinal discomfort and taste alterations. 15

Common Side Effects

Surgical Site Infection

A study on pregnant COVID-19 patients showed that those taking nirmatrelvir-ritonavir had a significantly higher rate of surgical site infections. 1

Preeclampsia

In pregnant COVID-19 patients, the study revealed a higher occurrence of preeclampsia among those treated with nirmatrelvir-ritonavir. 1

Taste Disturbances

Nirmatrelvir-ritonavir can cause alterations in taste perception. 15

Gastrointestinal Discomfort

Gastrointestinal discomfort is a potential side effect associated with nirmatrelvir-ritonavir. 15

Hyponatremia

Nirmatrelvir-ritonavir may lead to low sodium levels in the blood, a condition known as hyponatremia. 4

Side Effect Countermeasures

Surgical Site Infection

Maintaining proper hygiene before and after surgery can help reduce the risk of surgical site infection. Additionally, taking antibiotics as prescribed by a doctor is effective. 1

Preeclampsia

Regular blood pressure monitoring and doctor visits are crucial for managing the risk of preeclampsia. Medication as prescribed by a physician can also help manage the condition. 1

Taste Disturbances

Taste disturbances typically resolve upon discontinuation of nirmatrelvir-ritonavir. 15

Gastrointestinal Discomfort

Dietary adjustments and taking medications as directed by a doctor can help alleviate gastrointestinal discomfort. 15

Hyponatremia

Hyponatremia can potentially lead to serious complications. If symptoms arise, seeking immediate medical attention is vital. 4

Comparison between Studies

Common Points of Studies

A common finding across multiple studies is that nirmatrelvir-ritonavir is a promising treatment for COVID-19. Additionally, research consistently emphasizes the possibility of drug-drug interactions with other medications. 11

Differences between Studies

Studies have presented different results regarding the impact of nirmatrelvir-ritonavir on specific populations. For instance, a study on pregnant women indicated a potential increased risk of surgical site infections and preeclampsia. 1 Conversely, research on kidney transplant recipients has indicated nirmatrelvir-ritonavir’s safety and effectiveness. 11

Precautions for Application in Real Life

While nirmatrelvir-ritonavir shows promise in treating COVID-19, recognizing the possibility of side effects is important. 15 Individuals taking other medications should exercise caution due to potential drug interactions. 11 Consultation with a doctor is crucial for specific groups, such as pregnant women and organ transplant recipients. 1

Limitations of Current Research

Research on nirmatrelvir-ritonavir remains limited, leading to gaps in knowledge about its long-term safety and efficacy. 15 Additionally, many studies have small sample sizes and potential biases, which may limit the generalizability of their findings. 1

Future Research Directions

Further research is crucial to fully assess the long-term safety and efficacy of nirmatrelvir-ritonavir. 15 Particular attention should be paid to studying the drug in specific populations, such as pregnant women and organ transplant recipients. 1 Additional research on potential interactions with other medications is also necessary. 11

Conclusion

Nirmatrelvir-ritonavir shows promise as a treatment for COVID-19, especially in high-risk individuals. 17 However, it is essential to understand the potential for side effects. 15 If you are taking other medications, consulting with a doctor is crucial to avoid drug interactions. 11 Always follow your doctor’s instructions when taking nirmatrelvir-ritonavir and be aware of potential side effects. 15

Literature analysis of 17 papers
Positive Content
16
Neutral Content
1
Negative Content
0
Article Type
1
0
1
3
12
1.

Oral Nirmatrelvir-Ritonavir Use and Clinical Outcomes in Pregnant Patients With Coronavirus Disease 2019 (COVID-19).

Author: ToureBineta B, PanakamAisvarya, JohnsSarah L, ButlerSharlay K, TuomalaRuth E, DioufKhady

COVID-19 treatment
Preeclampsia
Surgical site infection

This study compared obstetric and COVID-19 outcomes between pregnant patients who did and did not take nirmatrelvir-ritonavir, an antiviral medication.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

2.

A retrospective cohort study of prescribing outcomes in outpatients treated with nirmatrelvir-Ritonavir for COVID-19 in an interdisciplinary community clinic.

Author: LeungValerie, GillSuzanne, LlanesAndrea, KhawajaArmughan, StaggAmanda, McCreadyJanine, JacubovichMariana, HoGrace, PowisJeff, KandelChristopher

COVID-19 severity prevention
Adverse drug events
Drug-drug interactions

This study investigated real-world prescribing outcomes of nirmatrelvir-ritonavir, including drug-drug interactions (DDI), adverse drug events (ADE), and treatment adherence in an outpatient community clinic setting.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

4.

A case report of severe hyponatremia secondary to Paxlovid-induced SIADH.

Author: MohamedSarah, Reda MostafaMostafa, Magdi EidMohamed, AbdelQadirYossef Hassan, AbdelghafarYomna Ali, SwedSarya, JahshanBishara, El-RadiWaddah Abd

COVID-19 treatment
Reduced viral load
Hyponatremia
SIADH

This article describes a case of a patient who developed severe hyponatremia after receiving nirmatrelvir-ritonavir (Paxlovid) for mild COVID-19 infection. The authors suggest that the hyponatremia may be secondary to Paxlovid.

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Language : English

5.

Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient.

Author: MaynardRobert D, BatesPhillip, Korpi-SteinerNichole

Mitigated transplant rejection
Prevented side effects
Drug interactions
Tacrolimus toxicity

This case report describes a liver transplant patient who experienced tacrolimus toxicity after receiving Paxlovid. The case highlights the importance of therapeutic drug monitoring and the need for a higher clinical reportable range for tacrolimus testing to better manage drug toxicity.

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Language : English

6.

Neurological side effects and drug interactions of antiviral compounds against SARS-CoV-2.

Author: AkhvledianiTamar, Bernard-ValnetRaphael, DiasSara P, EikelandRandi, PfauslerBettina, SellnerJohann,

Antiviral treatment

This article summarizes the available knowledge about antiviral drugs against SARS-CoV-2 from a neurologist's perspective.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

7.

Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19.

Author: KauerVictoria, TotschnigDavid, WaldenbergerFerdinand, AugustinMax, KarolyiMario, NägeliMichelle, WenischChristoph, ZoufalyAlexander

Hospitalization prevention
Symptom improvement
Side effects

All antiviral treatment options (SOT, N/R, and MOL) effectively prevented hospitalization in high-risk COVID-19 patients and were well tolerated. Side effects were pronounced in patients with N/R.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

8.

Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?

Author: HashemianSeyed Mohammad Reza, SheidaAmirhossein, TaghizadiehMohammad, MemarMohammad Yousef, HamblinMichael R, Bannazadeh BaghiHossein, Sadri NahandJavid, AsemiZatollah, MirzaeiHamed

Antiviral activity
Side effects

Nirmatrelvir is an antiviral drug that inhibits the SARS-CoV-2 main protease (Mpro), preventing viral replication. Paxlovid is a combination of nirmatrelvir and ritonavir, an HIV protease inhibitor that acts as a pharmacological enhancer for nirmatrelvir. This review summarizes the current literature on nirmatrelvir and ritonavir efficacy in treating SARS-CoV-2 infection, as well as their safety and possible side effects.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

14.

[COVID-19 treated with oral Nirmatrelvir-Ritonavir in 3 children].

Author: ShiS, DongN, DingY, WangC, YuanL, FangY S, WangB J, NiuY H, WeiZ Z, PuT, DongX Y, LuQ

COVID-19 treatment
Skin rash

Paxlovid, an antiviral drug, has been found to be effective and relatively safe in treating COVID-19 in children, offering a potential treatment option for pediatric patients.

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : Chinese

16.

Molecular Insights of SARS-CoV-2 Antivirals Administration: A Balance between Safety Profiles and Impact on Cardiovascular Phenotypes.

Author: NappiFrancesco, IervolinoAdelaide, Avtaar SinghSanjeet Singh

Antiviral efficacy
COVID-19 treatment
Cardiac side effects
Drug interactions
Safety concerns

Antiviral drugs, such as remdesivir, molnupinavir, and the combination nirmatrelvir-ritonavir, may have cardiovascular side effects.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

17.

An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19.

Author: SinghAwadhesh Kumar, SinghAkriti, SinghRitu, MisraAnoop

Effective antiviral
Reduced death
Reduced hospitalization

Molnupiravir is an oral antiviral drug that has recently received emergency use authorization (EUA) for the treatment of COVID-19 in the USA, UK, and India. This systematic review found that molnupiravir could be a useful agent in non-pregnant unvaccinated adults with COVID-19 who are at increased risk of severity including hospitalization. It is effective only when used within 5 days of onset of symptoms. A 5-day course seems to be safe without any obvious short-term side effects.

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.